TL;DR: Fibromyalgia is a chronic pain condition that must be declared on UK travel insurance applications. Insurers assess symptom severity, medication type, and whether associated conditions such as depression or fatigue disorders are present. Mainstream providers may load premiums or exclude the condition; specialist medical travel insurers can often offer broader cover. Full declaration is legally required under the Consumer Insurance (Disclosure and Representations) Act 2012.
KEY FACTS
|
How Insurers Assess Fibromyalgia for Travel Insurance Purposes
Fibromyalgia presents a particular underwriting challenge for travel insurers because it is a condition characterised by widespread chronic pain, fatigue, and cognitive difficulties, without a single objective diagnostic marker. Unlike conditions such as diabetes where blood glucose readings provide quantifiable data, fibromyalgia is assessed on the basis of reported symptoms, functional impact, and the range of medications prescribed. Insurers typically ask medical screening questions focused on whether the applicant has been hospitalised for the condition in the past 12 to 24 months, whether symptoms are currently controlled and stable, which medications are prescribed and at what dose, and whether any associated or co-existing conditions such as depression, anxiety, chronic fatigue syndrome, or irritable bowel syndrome are also present. This last point is particularly important: fibromyalgia frequently co-exists with other conditions, and each must be declared separately. Failing to declare a co-existing depression or IBS, even if considered by the applicant as part of the same fibromyalgia presentation, can create non-disclosure risk for claims related to those conditions. A traveller with fibromyalgia that is well-managed on a stable medication regimen, with no recent hospitalisations and no significant functional deterioration, will typically receive a more favourable assessment than someone whose symptoms have worsened recently, whose medication has been escalated, or who has required mental health treatment as a result of the condition's impact.
The Non-Disclosure Risk for Fibromyalgia and Associated Conditions
The Consumer Insurance (Disclosure and Representations) Act 2012 requires insurance applicants to take reasonable care not to make a misrepresentation. For people with fibromyalgia, the most common non-disclosure risk is not necessarily the fibromyalgia itself - which most applicants know to declare - but the constellation of associated conditions that may accompany it. Fibromyalgia is associated with a range of comorbidities including depression, anxiety disorders, chronic fatigue syndrome, irritable bowel syndrome, and temporomandibular joint disorders. If any of these are present and have been diagnosed or treated, they must be declared separately. An insurer investigating a claim for emergency psychiatric treatment abroad may seek to establish whether depression was a known diagnosis at application. If it was present but not declared - even if the applicant considered it a symptom of their fibromyalgia rather than a separate condition - this can constitute a material non-disclosure. The Financial Ombudsman Service's guidance on non-disclosure cases confirms that insurers must demonstrate a causal link between undisclosed information and the claim, and that innocent non-disclosure typically results in a proportional reduction rather than full claim repudiation. However, the cost and stress of a disputed claim in the context of a medical emergency abroad makes prevention through accurate declaration far preferable to reliance on FOS adjudication after the fact.
Medication Management and Travelling Abroad with Fibromyalgia
Managing fibromyalgia medication during international travel requires advance planning. Common medications prescribed for fibromyalgia include low-dose tricyclic antidepressants such as amitriptyline, serotonin-norepinephrine reuptake inhibitors (SNRIs) such as duloxetine, gabapentinoids such as pregabalin and gabapentin, and in some cases low-dose naltrexone. Several of these medications, particularly pregabalin, are classified as controlled drugs in the UK under the Misuse of Drugs Act 1971 and are subject to import restrictions in many countries. The UK Government's guidance on travelling with medicines, available at gov.uk, indicates that travellers carrying more than three months' supply of a controlled drug require a personal licence from the Home Office. For shorter quantities, carrying a GP letter confirming the prescription and diagnosis is strongly advisable. The UK Government's foreign travel advice at gov.uk/foreign-travel-advice carries country-specific information on controlled drug regulations. Some countries have strict restrictions on importing pregabalin or gabapentin, and travellers should check in advance with the embassy or consulate of their destination. From an insurance perspective, if a traveller requires emergency medical care abroad for a condition exacerbated by fibromyalgia - such as a severe pain crisis requiring inpatient management - the cost can be substantial, and cover that includes the declared fibromyalgia diagnosis is essential to avoid out-of-pocket exposure.
Specialist Travel Insurance Options for Fibromyalgia
Where mainstream insurers apply a full fibromyalgia exclusion or are unable to offer suitable cover, specialist medical travel insurance providers can often offer a more appropriate alternative. The MoneyHelper travel insurance directory at moneyhelper.org.uk is a government-backed resource listing specialist providers for pre-existing medical conditions. BIBA's find-a-broker service at biba.org.uk connects applicants with brokers experienced in arranging cover for complex chronic conditions. Specialist insurers conduct more detailed underwriting for fibromyalgia, gathering information on the specific fibromyalgia impact scale or functional assessment used by the applicant's consultant, the full medication list, and the history of flares or hospitalisations. This allows them to price the condition more accurately and, in many cases, to include fibromyalgia-related emergency claims that mainstream providers exclude. When comparing specialist quotes, travellers should pay particular attention to whether the policy covers the full range of fibromyalgia symptoms - not just the musculoskeletal pain element but also cognitive symptoms, fatigue crises, and any associated mental health conditions - and whether the cover extends to cancellation if fibromyalgia prevents travel. Cancellation cover for pre-existing conditions is a specific and often contested area of travel insurance: some policies include cancellation for exacerbation of a declared pre-existing condition, while others specifically exclude it. Reading the cancellation section of the policy terms with care before purchasing is strongly advisable.
Cancellation Cover and Fibromyalgia Flares: A Critical Policy Detail
One of the most practically significant cover questions for travellers with fibromyalgia is whether the policy will pay a cancellation claim if a flare prevents travel. This is distinct from emergency medical cover abroad and is an area where policy wordings differ substantially. Standard travel insurance cancellation sections typically cover cancellation arising from illness or injury that occurs after the policy is taken out and prevents travel. For travellers with a chronic condition such as fibromyalgia, the question is whether a deterioration of a pre-existing condition qualifies. Policies that include fibromyalgia as a declared and accepted condition will generally also cover cancellation arising from a documented flare of that condition that prevents the trip, provided the policy was purchased before the flare began. Policies that exclude fibromyalgia from cover - either because it was not declared or because the insurer applied an exclusion - will not cover cancellation arising from a fibromyalgia flare. Given that fibromyalgia is by nature an unpredictable condition where symptom severity can change significantly over short periods, cancellation protection is arguably as important as emergency medical cover. Travellers should look specifically for policies that state pre-existing condition deterioration is included within the cancellation section, not merely assumed. If a policy is ambiguous on this point, asking the insurer for written confirmation of the position before purchasing is advisable and provides additional protection in any subsequent dispute.
| Editorial Disclaimer: Kaeltripton.com is an independent editorial publisher and is not authorised or regulated by the Financial Conduct Authority. Content is for informational purposes only and does not constitute financial, investment, tax, legal or regulatory advice. Always verify rates and product details with the relevant provider, the FCA register, HMRC or the Bank of England before any financial decision. |
Frequently Asked Questions
Does fibromyalgia count as a pre-existing condition for travel insurance?
Yes. Fibromyalgia is a chronic condition that falls within the definition of a pre-existing medical condition used by virtually all UK travel insurers. Any policy's pre-existing condition screening process will require it to be declared. This applies regardless of how long ago the diagnosis was made or how well-managed it currently is. Any associated conditions such as depression or IBS must also be declared separately.
Can I get travel insurance with fibromyalgia if my symptoms are severe?
Yes, though the options and cost will vary. Severe or frequently flaring fibromyalgia may result in premium loadings or exclusions from mainstream insurers. Specialist medical travel insurance providers - accessible via the MoneyHelper directory at moneyhelper.org.uk - are equipped to assess more complex presentations and may offer cover that includes fibromyalgia-related emergencies, including cancellation for documented flares.
Will my travel insurance cover cancellation if fibromyalgia stops me travelling?
Only if the policy specifically includes cancellation arising from pre-existing condition deterioration, and only if fibromyalgia was declared and accepted in the policy. Policies that exclude the condition will not cover a fibromyalgia flare as a reason for cancellation. Reading the cancellation section of the policy wording carefully before purchasing is essential for travellers whose condition may unpredictably prevent travel.
Do I need to declare pregabalin when applying for travel insurance?
Yes. The medication declared on a travel insurance application should reflect the full current prescription. Pregabalin is a significant medication used in fibromyalgia management, and its presence in the declared prescription list assists underwriters in assessing the severity of the condition. Travellers should also note that pregabalin is a controlled drug in the UK and may be subject to import restrictions in some countries; checking with the destination country's embassy in advance is advisable.
Where can I complain if my fibromyalgia travel claim is refused?
If a claim is refused and the insurer's internal complaints process does not resolve the matter within eight weeks, the complaint can be taken to the Financial Ombudsman Service at financial-ombudsman.org.uk free of charge. The FOS can direct insurers to pay claims where the decision is found to be unreasonable. Complaints must be submitted within six months of the insurer's final response letter.
How We Verified This Guide
This guide was researched against primary UK sources including NHS guidance on fibromyalgia, the Consumer Insurance (Disclosure and Representations) Act 2012 via legislation.gov.uk, the Equality Act 2010 via legislation.gov.uk, the FCA Consumer Duty policy statement PS22/9, the Financial Ombudsman Service's published guidance on travel insurance and non-disclosure, the MoneyHelper travel insurance directory, and UK Government guidance on travelling with controlled drugs. Last reviewed May 2026 by Chandraketu Tripathi, finance editor at Kaeltripton.
